Abstract
Optogenetics, a technique based on natural or genetically engineered light-sensitive proteins, combines genetic manipulation and optics offering unprecedented and reversible opportunities for controlling cell functions by light with a millisecond-scale temporal resolution, allowing the user to keep up with fast biological information.
Optogenetics, applied to cell-based high-throughput screening (HTS) assays in the early stages of drug discovery, typically involves the generation of a recipient cell line stably expressing an optogenetic actuator (a light-sensitive ion channel, pump, or enzyme) together with the target of interest. The light-driven modulation of the target achieved triggers a biological response that can be followed by standard optical readouts and is easily detectable by HTS-compatible platforms.
Herein we describe how a series of HTS-compatible platform working cellular assays applying optogenetics techniques was established at Axxam, including examples of fluorescence plate reader assays with improved control of cellular excitability over time. Moreover, we show how electrophysiology can be used to validate the optogenetics-induced mechanism of action of a cell line, validating the assay principle and mode of action before its final application in an HTS-compatible format. We also show how optogenetic vectors can be easily inserted into induced pluripotent stem-derived cells (iPSCs) to achieve fast control of specific cell events and develop relevant assays in a miniaturized format for drug discovery screening campaigns. Finally, we discuss how image-based optical approaches have also been shown to be more relevant for validating cellular signals when combined with fine-tuned optogenetic stimulation.
This is a preview of subscription content, log in via an institution to check access.
References and Further Reading
Agus V, Silvio AD, Rolland JF et al (2015) Bringing the light to high throughput screening: use of optogenetic tools for the development of recombinant cellular assays. In: Optical techniques in neurosurgery, neurophotonics, and optogenetics II. SPIE, Bellingham, pp 258–266
Agus V, Flak TA, Picardi P et al (2021) Parallel all-optical assay to study use-dependent functioning of voltage-gated ion channels in a miniaturized format. SLAS Discov 26:460–469. https://doi.org/10.1177/2472555220976083
Baruscotti M, Bucchi A, Difrancesco D (2005) Physiology and pharmacology of the cardiac pacemaker (“funny”) current. Pharmacol Ther 107:59–79. https://doi.org/10.1016/j.pharmthera.2005.01.005
Benarroch EE (2013) HCN channels: function and clinical implications. Neurology 80:304–310. https://doi.org/10.1212/WNL.0b013e31827dec42
Bernal Sierra YA, Rost BR, Pofahl M et al (2018) Potassium channel-based optogenetic silencing. Nat Commun 9:4611. https://doi.org/10.1038/s41467-018-07038-8
Bub G, Daniels MJ (2020) Feasibility of using adjunctive optogenetic technologies in cardiomyocyte phenotyping – from the single cell to the whole heart. Curr Pharm Biotechnol 21:752–764. https://doi.org/10.2174/1389201020666190405182251
Bugaj LJ, Lim WA (2019) High-throughput multicolor optogenetics in microwell plates. Nat Protoc 14:2205–2228. https://doi.org/10.1038/s41596-019-0178-y
Chang Y-F, Su W-C, Su C-C et al (2022) High-throughput optical controlling and recording calcium signal in iPSC-derived cardiomyocytes for toxicity testing and phenotypic drug screening. J Vis Exp. https://doi.org/10.3791/63175
Chow BY, Han X, Dobry AS et al (2010) High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature 463:98–102. https://doi.org/10.1038/nature08652
Entcheva E, Kay MW (2021) Cardiac optogenetics: a decade of enlightenment. Nat Rev Cardiol 18:349–367. https://doi.org/10.1038/s41569-020-00478-0
Ernst OP, Lodowski DT, Elstner M et al (2014) Microbial and animal rhodopsins: structures, functions, and molecular mechanisms. Chem Rev 114:126–163. https://doi.org/10.1021/cr4003769
Gemel J, Valiunas V, Brink PR, Beyer EC (2004) Connexin43 and connexin26 form gap junctions, but not heteromeric channels in co-expressing cells. J Cell Sci 117:2469–2480. https://doi.org/10.1242/jcs.01084
Govorunova EG, Sineshchekov OA, Janz R et al (2015) NEUROSCIENCE. Natural light-gated anion channels: a family of microbial rhodopsins for advanced optogenetics. Science 349:647–650. https://doi.org/10.1126/science.aaa7484
Harada K, Ito M, Wang X et al (2017) Red fluorescent protein-based cAMP indicator applicable to optogenetics and in vivo imaging. Sci Rep 7:7351. https://doi.org/10.1038/s41598-017-07820-6
Joshi J, Rubart M, Zhu W (2019) Optogenetics: background, methodological advances and potential applications for cardiovascular research and medicine. Front Bioeng Biotechnol 7:466. https://doi.org/10.3389/fbioe.2019.00466
Kleinlogel S, Feldbauer K, Dempski RE et al (2011) Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh. Nat Neurosci 14:513–518. https://doi.org/10.1038/nn.2776
Kuryshev YA, Brown AM, Duzic E, Kirsch GE (2014) Evaluating state dependence and subtype selectivity of calcium channel modulators in automated electrophysiology assays. Assay Drug Dev Technol 12:110–119. https://doi.org/10.1089/adt.2013.552
Lee C, Lavoie A, Liu J et al (2020) Light up the brain: the application of optogenetics in cell-type specific dissection of mouse brain circuits. Front Neural Circuits 14:18. https://doi.org/10.3389/fncir.2020.00018
Lim DH, Ledue J, Mohajerani MH et al (2013) Optogenetic approaches for functional mouse brain mapping. Front Neurosci 7:54. https://doi.org/10.3389/fnins.2013.00054
Mager T, Lopez de la Morena D, Senn V et al (2018) High frequency neural spiking and auditory signaling by ultrafast red-shifted optogenetics. Nat Commun 9:1750. https://doi.org/10.1038/s41467-018-04146-3
Mahn M, Gibor L, Patil P et al (2018) High-efficiency optogenetic silencing with soma-targeted anion-conducting channelrhodopsins. Nat Commun 9:4125. https://doi.org/10.1038/s41467-018-06511-8
Molina-Martínez B, Jentsch L-V, Ersoy F et al (2022) A multimodal 3D neuro-microphysiological system with neurite-trapping microelectrodes. Biofabrication 14. https://doi.org/10.1088/1758-5090/ac463b
Molokanova E, Mercola M, Savtchenko A (2017) Bringing new dimensions to drug discovery screening: impact of cellular stimulation technologies. Drug Discov Today 22:1045–1055. https://doi.org/10.1016/j.drudis.2017.01.015
Nagel G, Ollig D, Fuhrmann M et al (2002) Channelrhodopsin-1: a light-gated proton channel in green algae. Science 296:2395–2398. https://doi.org/10.1126/science.1072068
O’Shea C, Holmes AP, Winter J et al (2019) Cardiac optogenetics and optical mapping – overcoming spectral congestion in all-optical cardiac electrophysiology. Front Physiol 10:182. https://doi.org/10.3389/fphys.2019.00182
Odaka H, Arai S, Inoue T, Kitaguchi T (2014) Genetically-encoded yellow fluorescent cAMP indicator with an expanded dynamic range for dual-color imaging. PLoS One 9:e100252. https://doi.org/10.1371/journal.pone.0100252
Pan Z-H, Ganjawala TH, Lu Q et al (2014) ChR2 mutants at L132 and T159 with improved operational light sensitivity for vision restoration. PLoS One 9:e98924. https://doi.org/10.1371/journal.pone.0098924
Reshetnikov VV, Smolskaya SV, Feoktistova SG, Verkhusha VV (2022) Optogenetic approaches in biotechnology and biomaterials. Trends Biotechnol 40:858–874. https://doi.org/10.1016/j.tibtech.2021.12.007
Sridharan S, Gajowa MA, Ogando MB et al (2022) High-performance microbial opsins for spatially and temporally precise perturbations of large neuronal networks. Neuron 110:1139–1155.e6. https://doi.org/10.1016/j.neuron.2022.01.008
Stieber J, Wieland K, Stöckl G et al (2006) Bradycardic and proarrhythmic properties of sinus node inhibitors. Mol Pharmacol 69:1328–1337. https://doi.org/10.1124/mol.105.020701
Stierl M, Stumpf P, Udwari D et al (2011) Light modulation of cellular cAMP by a small bacterial photoactivated adenylyl cyclase, bPAC, of the soil bacterium Beggiatoa. J Biol Chem 286:1181–1188. https://doi.org/10.1074/jbc.M110.185496
Vasilyev DV, Shan QJ, Lee YT et al (2009) A novel high-throughput screening assay for HCN channel blocker using membrane potential-sensitive dye and FLIPR. J Biomol Screen 14:1119–1128. https://doi.org/10.1177/1087057109345526
Werley CA, Chien M-P, Cohen AE (2017) Ultrawidefield microscope for high-speed fluorescence imaging and targeted optogenetic stimulation. Biomed Opt Express 8:5794–5813. https://doi.org/10.1364/BOE.8.005794
Zhang H, Cohen AE (2017) Optogenetic approaches to drug discovery in neuroscience and beyond. Trends Biotechnol 35:625–639. https://doi.org/10.1016/j.tibtech.2017.04.002
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Agus, V. et al. (2023). Optogenetic and High-Throughput Drug Discovery. In: Hock, F.J., Pugsley, M.K. (eds) Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Springer, Cham. https://doi.org/10.1007/978-3-030-73317-9_145-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-73317-9_145-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-73317-9
Online ISBN: 978-3-030-73317-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences